StockClub

NNNN

NNNNAnbio Biotechnology Class A Ordinary Shares$ --
Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
5M USD
YoY -20.8%
Operating Income
4M USD
YoY -5.4%
Net Income
4M USD
YoY +6.7%
EPS
0.09$
YoY +2.8%

Revenue

$5M
FY2023 Q2$3.3M
$3.3M
Q2
FY2023 Q4$7.3M
$7.3M
Q4
FY2024 Q2$6.3M
$6.3M
Q2
FY2024 Q4$8.9M
$8.9M
Q4
FY2025 Q2$5M
$5M
Q2
Actual
$-1.3M (-20.8%)

Net Income

$4.1M
FY2023 Q2$1.6M
$1.6M
Q2
FY2023 Q4$2.4M
$2.4M
Q4
FY2024 Q2$3.9M
$3.9M
Q2
FY2024 Q4$2.6M
$2.6M
Q4
FY2025 Q2$4.1M
$4.1M
Q2
Actual
+$260,554 (+6.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$4.4M
FY2021
$4.4M
FY2022
Actual:$23.5M
FY2022
$23.5M
FY2023
Actual:$6.7M
FY2023
$6.7M
FY2024
Actual:$8.2M
FY2024
$8.2M

Analyst Estimates

No forecast data